Atlas Trials

Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

Clinical trial NCT03964649 · COMPLETED

Trial details

NCT number
NCT03964649
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Arthritis, Rheumatoid
Start date
2019-01-01
Primary completion
2020-04-06
Enrollment
7308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.